Sysmex (OTCMKTS:SSMXY) Shares Gap Up – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXYGet Free Report) gapped up before the market opened on Friday . The stock had previously closed at $10.30, but opened at $11.11. Sysmex shares last traded at $10.59, with a volume of 5,151 shares.

Wall Street Analyst Weigh In

SSMXY has been the subject of a number of recent research reports. Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research report on Thursday, October 9th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

View Our Latest Research Report on Sysmex

Sysmex Price Performance

The business has a 50-day moving average of $12.19 and a two-hundred day moving average of $15.03. The company has a current ratio of 3.37, a quick ratio of 2.49 and a debt-to-equity ratio of 0.12. The firm has a market cap of $6.68 billion, a P/E ratio of 21.21 and a beta of 1.16.

Sysmex (OTCMKTS:SSMXYGet Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Sysmex had a return on equity of 10.20% and a net margin of 9.35%.The firm had revenue of $826.60 million for the quarter, compared to analyst estimates of $880.80 million. On average, sell-side analysts anticipate that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

See Also

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.